Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson Explores Sale of Cerenovus for $1 Billion

February 16, 2025
According to reports, pharmaceutical giant Johnson & Johnson is looking to sell its stroke care business, Cerenovus, for a staggering $1 billion.
The company is said to be focusing on its core business areas and streamlining its operations. Cerenovus, which develops devices for the treatment of stroke, has been struggling in recent years, facing market challenges and regulatory hurdles. This move is seen as a strategic decision by Johnson & Johnson to divest from non-core businesses and invest in areas with higher growth potential. Experts suggest that this sale could attract significant interest from potential buyers in the medical technology sector. For investors looking to capitalize on this opportunity, it is recommended to seek professional advice and consider the forecasted movement of Johnson & Johnson's stock by industry experts from Stocks Prognosis.

Find out how the JOHNSON & JOHNSON rate is expected to change

Get Forecast for JNJ

Investor opinions & comments:

It will be interesting to see how this sale impacts Johnson & Johnson's stock price in the short and long term
— from BudgetBobby at 02-19-2025 15:43
I'm not sure if selling Cerenovus is the best decision for Johnson & Johnson. Couldn't they find a way to turn the business around?
— from WealthyWes at 02-19-2025 13:57
I'm excited to see where Johnson & Johnson will invest the proceeds from the sale of Cerenovus
— from OwenSullivan at 02-19-2025 02:37
This is a smart move by Johnson & Johnson to focus on their core business and invest in areas with higher growth potential
— from AudreyRussell at 02-19-2025 02:16
This move by Johnson & Johnson shows their commitment to maximizing shareholder value
— from JessicaMoore at 02-18-2025 19:51
I wonder what impact this sale will have on Johnson & Johnson's overall financial performance in the coming years
— from LoganWard at 02-18-2025 03:40
I'm confident that Johnson & Johnson will attract potential buyers who see the value in Cerenovus's stroke care business
— from BudgetBobby at 02-18-2025 02:14
I'm optimistic about Johnson & Johnson's future growth prospects as they focus on their core business and streamline operations
— from JessicaHall at 02-17-2025 17:50
With the market challenges and regulatory hurdles Cerenovus has faced, I'm not sure if there will be significant interest from potential buyers
— from SmartSteve at 02-17-2025 03:43
I'm really interested in learning more about the potential buyers in the medical technology sector
— from MoneyMonique at 02-16-2025 21:33
This could be a great opportunity for investors to capitalize on Johnson & Johnson's strategic decision
— from SavingsSamantha at 02-16-2025 13:20
I'm skeptical about the $1 billion valuation. Is Cerenovus really worth that much?
— from WealthyWillie at 02-16-2025 04:11
If you want to leave a comment, then you need Login or Register





Other news for JNJ

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....

JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....



Related news

REGNJanuary 24, 2025Regeneron Pharmaceuticals, Inc. Announces Positive Results from Clinical Trial of its Breakthrough Drug  ~1 min.

Regeneron Pharmaceuticals, Inc., a leading biotechnology company, has recently announced positive results from a clinical trial of its groundbreaking drug....

AZNJanuary 1, 2025New breakthrough in medical research announced by AstraZeneca PLC AZN  ~2 min.

Leading pharmaceutical company AstraZeneca PLC AZN has made a groundbreaking discovery in the field of medical research....

GSKJanuary 2, 2025GSK PLC introduces groundbreaking technology to revolutionize healthcare industry  ~2 min.

GSK PLC, a leading pharmaceutical company, has unveiled its latest innovation aimed at transforming the healthcare industry....

VRTXMarch 19, 2025Investing in Vertex Pharmaceuticals: A Lucrative Opportunity for Biotech Enthusiasts  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has emerged as one of the most promising biotech stocks in the market, attracting the attention of top investors....

LLYDecember 1, 2024Eli Lilly and Company Invests $4.5 Billion in New Medicine Foundry for Advanced Drug Manufacturing  ~2 min.

Eli Lilly and Company, a leading pharmaceutical company, has recently announced a massive investment of $4.5 billion in the establishment of a state-of-the-art medicine foundry....